Keyphrases
Glucose Metabolism
100%
Systolic Heart Failure
100%
Galectin-3 (Gal-3)
100%
Fibulin-1
100%
Left Ventricular Contractile Reserve
100%
Heart Failure Patients
71%
Three-level
28%
Cardiac Fibrosis
28%
Plasma Parameters
14%
Non-associated
14%
Blood Samples
14%
Impaired Glucose Tolerance
14%
Estimated Glomerular Filtration Rate
14%
Patients with Diabetes
14%
Non-diabetic
14%
Adverse Prognosis
14%
Patients with Heart Failure
14%
Oral Glucose Tolerance Test
14%
Impaired Glucose Metabolism
14%
Normal Glucose Tolerance
14%
Functional Capacity
14%
Circulating Biomarkers
14%
Heart Failure with Preserved Ejection Fraction (HFpEF)
14%
Low-dose Dobutamine
14%
Dobutamine Echocardiography
14%
DM Patients
14%
Chamber Stiffness
14%
Medicine and Dentistry
Glucose Metabolism
100%
Galectin 3
100%
Systolic Heart Failure
100%
Fibulin
100%
Heart Failure
71%
Biological Marker
28%
Cardiac Fibrosis
28%
Impaired Glucose Tolerance
14%
Diabetes Mellitus
14%
Echocardiography
14%
Glomerular Filtration Rate
14%
Low Drug Dose
14%
Blood Sampling
14%
Functional Status
14%
Patient with Diabetes
14%
Oral Glucose Tolerance Test
14%
Glucose Tolerance
14%
Dobutamine
14%
Heart Failure with Reduced Ejection Fraction
14%
Biochemistry, Genetics and Molecular Biology
Glucose Metabolism
100%
Fibulin
100%
Galectin-3
100%
Blood Level
14%
Impaired Glucose Tolerance
14%
Low Drug Dose
14%
Rigidity
14%
Glomerulus Filtration
14%
Glucose Test
14%
Glucose Tolerance Test
14%
Blood Sampling
14%
Functional Status
14%
Heart Ejection Fraction
14%
Dobutamine
14%